http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-970001327-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58 |
filingDate | 1996-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1997-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-970001327-A |
titleOfInvention | Substituted Piperidine Derivatives |
abstract | The present invention is the following general formula (1)n n n (One)n n n [Wherein, R 1 represents an aryl or heteroaryl group having at least one substituent, R 2 represents an alkyl group, an alkenyl group, or an aralkyl group, R 3 represents a hydrogen atom or an alkyl group, and R 4 represents a hydrogen atom , An aryl group, heteroaryl group, aralkyl group or heteroaralkyl group having an alkyl group or at least one substituent group]. Also disclosed are drugs containing this compound. Since the compound of the present invention has excellent anticholinergic and calcium antagonistic effects and suppresses reflex ray bladder contraction, it is possible to prevent and cure urinary disorders such as urinary incontinence, urinary incontinence, and other diseases such as urinary anemia, neurogenic bladder, enuresis, labile bladder, and chronic cystitis. Useful as |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100545092-B1 |
priorityDate | 1995-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.